Advanced Respiratory Technologies, Inc.

Advanced Respiratory Technologies, Inc. is a small, for-profit corporate entity headquartered in Pittsburgh, Pennsylvania, specializing in developing advanced respiratory and pulmonary medical technologies. The company is registered in SAM.gov through November 15, 2025, and focuses on creating innovative medical devices and support systems for respiratory and extracorporeal life support applications, with a particular emphasis on military and medical transport scenarios. Their core competency appears to be designing and manufacturing sophisticated respiratory assist devices, gas exchangers, and medical support systems that can be used in critical medical environments, especially for military medical evacuation and transport.

Through federal contract awards, Advanced Respiratory Technologies, Inc. has primarily engaged in Small Business Innovation Research (SBIR) contracts with the Defense Health Agency and Department of the Army Medical Command. These contracts, totaling approximately $1.55 million, have been dedicated to developing the Coaxial Femoral Cannula (CFC) for far forward extracorporeal life support initiation and prolonged field care. Both contract awards were set aside for small businesses and focused on Phase I and Phase II research and development efforts. The contracts represent a progressive approach to developing medical technologies specifically designed for military medical support, with a focus on respiratory and life support innovations that can be deployed in challenging field environments.

In terms of federal grant awards, Advanced Respiratory Technologies, Inc. has participated in multiple sub-grant and prime grant projects primarily centered on pulmonary assist systems and advanced medical support technologies. Their prime grant from the Defense Health Agency supports advancing pulmonary assist systems for military transport. As a sub-grantee, they have collaborated with prestigious institutions like Johns Hopkins University, Vanderbilt University Medical Center, and Carnegie Mellon University. Their specific roles in these grants have included manufacturing gas exchangers, designing right atrial attachments, providing technical support for system integration, and contributing to research and development of innovative medical technologies for chronic lung disease patients and advanced cardiopulmonary support systems.